Literature DB >> 25182061

Prolonged treatment with large doses of fosfomycin plus vancomycin and amikacin in a case of bacteraemia due to methicillin-resistant Staphylococcus epidermidis and IMP-8 metallo-β-lactamase-producing Klebsiella oxytoca.

Salvador Vergara-López1, M Carmen Domínguez2, M Carmen Conejo3, Álvaro Pascual4, Jesús Rodríguez-Baño5.   

Abstract

Entities:  

Keywords:  adverse effects; bacteraemia treatment; carbapenem resistance; carbapenemases; infectious endocarditis

Mesh：

Substances：

Year:  2014        PMID： 25182061     DOI： 10.1093/jac/dku341

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Activity of fosfomycin and amikacin against fosfomycin-heteroresistant Escherichia coli strains in a hollow-fiber infection model.

Authors:  I Portillo-Calderón; M Ortiz-Padilla; B de Gregorio-Iaria; V Merino-Bohorquez; J Blázquez; J Rodríguez-Baño; J M Rodríguez-Martínez; A Pascual; F Docobo-Pérez
Journal:  Antimicrob Agents Chemother       Date:  2021-03-08       Impact factor: 5.191

2.  Urinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin Uptake.

Authors:  G Martín-Gutiérrez; F Docobo-Pérez; J Rodriguez-Beltrán; J M Rodríguez-Martínez; J Aznar; A Pascual; J Blázquez
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

3.  Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence.

Authors:  Jing Yang; Haiyan Long; Ya Hu; Yu Feng; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2021-12-01       Impact factor: 50.129

4.  In vitro antibacterial effect of fosfomycin combination therapy against colistin-resistant Klebsiella pneumoniae.

Authors:  Wei Yu; Qixia Luo; Qingyi Shi; Chen Huang; Xiao Yu; Tianshui Niu; Kai Zhou; Jiajie Zhang; Yonghong Xiao
Journal:  Infect Drug Resist       Date:  2018-04-24       Impact factor: 4.003

5.  Efficacy of Fosfomycin and Its Combination With Aminoglycosides in an Experimental Sepsis Model by Carbapenemase-Producing Klebsiella pneumoniae Clinical Strains.

Authors:  Tania Cebrero-Cangueiro; Gema Labrador-Herrera; Álvaro Pascual; Caridad Díaz; Jesús Rodríguez-Baño; Jerónimo Pachón; José P Del Palacio; María E Pachón-Ibáñez; M Carmen Conejo
Journal:  Front Med (Lausanne)       Date:  2021-03-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.